Active	Status	Sponsor type	Region	Phase	Filter
4 Active 6 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Krause, David S
MedOPT, NCT03468309: Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population	Completed	N/A	53	US	Genecept Assay and G-DIG decision tool	Seattle Institute for Biomedical and Clinical Research, Genomind, LLC	Pharmacogenetic Testing	04/19	04/24
Wood, Amanda E
MedOPT, NCT03468309: Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population	Completed	N/A	53	US	Genecept Assay and G-DIG decision tool	Seattle Institute for Biomedical and Clinical Research, Genomind, LLC	Pharmacogenetic Testing	04/19	04/24
NCT00512070: Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine	Completed	N/A	40	US	olanzapine and melatonin, Olanzapine (Zyprexa)	Seattle Institute for Biomedical and Clinical Research, Eli Lilly and Company	Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Obesity, Metabolic Syndrome	12/10	12/24
NCT05776719: Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma	Recruiting	N/A	134	US	Health & Wellness, Warrior Renew	Seattle Institute for Biomedical and Clinical Research, United States Department of Defense	Military Sexual Trauma (MST), Post Traumatic Stress Disorder	11/26	01/30